Cargando…
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development
l-type calcium channel (LTCC) antagonists have been used in bipolar disorder for over 30 years, without becoming an established therapeutic approach. Interest in this class of drugs has been rekindled by the discovery that LTCC genes are part of the genetic aetiology of bipolar disorder and related...
Autores principales: | Cipriani, A, Saunders, K, Attenburrow, M-J, Stefaniak, J, Panchal, P, Stockton, S, Lane, T A, Tunbridge, E M, Geddes, J R, Harrison, P J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030455/ https://www.ncbi.nlm.nih.gov/pubmed/27240535 http://dx.doi.org/10.1038/mp.2016.86 |
Ejemplares similares
-
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
por: Tunbridge, EM, et al.
Publicado: (2017) -
The Emerging Neurobiology of Bipolar Disorder
por: Harrison, Paul J., et al.
Publicado: (2018) -
Cellular calcium in bipolar disorder: systematic review and meta-analysis
por: Harrison, Paul J., et al.
Publicado: (2019) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)